You have 9 free searches left this month | for more free features.

VX-950-C134

Showing 1 - 25 of 321

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)

Active, not recruiting
  • Glioblastoma Multiforme of Brain
  • +2 more
  • C134
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 19, 2022

Upper Limb Spasticity Trial (ABBV-950, BOTOX, Placebo for ABBV-950)

Not yet recruiting
  • Upper Limb Spasticity
  • ABBV-950
  • +2 more
  • (no location specified)
Jul 14, 2023

Pain Trial (VX-548, Moxifloxacin, Moxifloxacin Placebo)

Not yet recruiting
  • Pain
  • (no location specified)
Apr 5, 2023

Cystic Fibrosis Trial (VX-121/TEZ/D-IVA)

Recruiting
  • Cystic Fibrosis
  • Aurora, Colorado
  • +16 more
Jan 19, 2023

Cystic Fibrosis Trial (VX-828, Placebo, Itraconazole)

Not yet recruiting
  • Cystic Fibrosis
  • (no location specified)
Nov 23, 2023

Lung Non-Small Cell Squamous Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (Berzosertib, Carboplatin,

Recruiting
  • Lung Non-Small Cell Squamous Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Los Angeles, California
  • +34 more
Jan 20, 2023

Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • TRK-950
  • +2 more
  • Chuo Ku, Japan
    Osaka International Cancer Institute
Sep 14, 2023

Cystic Fibrosis Trial (VX-121/TEZ/D-IVA)

Not yet recruiting
  • Cystic Fibrosis
  • (no location specified)
Sep 7, 2022

Pain Trial (VX-548)

Not yet recruiting
  • Pain
  • (no location specified)
Apr 28, 2023

Pain Trial in Harrow (VX-973, Placebo, Midazolam)

Recruiting
  • Pain
  • Harrow, United Kingdom
    PAREXEL International
May 17, 2023

Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)

Active, not recruiting
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +169 more
Dec 22, 2022

Type 1 Diabetes Trial (VX-264)

Not yet recruiting
  • Type 1 Diabetes
  • (no location specified)
Mar 16, 2023

Cystic Fibrosis Trial in Miami, San Antonio (VX-121/TEZ/D-IVA)

Recruiting
  • Cystic Fibrosis
  • Miami, Florida
  • +1 more
Aug 4, 2022

Pain Trial in United States (VX-548)

Recruiting
  • Pain
  • Tucson, Arizona
  • +5 more
Feb 2, 2023

Alpha-1 Antitrypsin Deficiency Trial (VX-668, Placebo)

Not yet recruiting
  • Alpha-1 Antitrypsin Deficiency
  • (no location specified)
Feb 3, 2023

Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)

Recruiting
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +128 more
Aug 24, 2022

Focal Segmental Glomerulosclerosis (FSGS) Trial (VX-147)

Not yet recruiting
  • Focal Segmental Glomerulosclerosis (FSGS)
  • (no location specified)
Jul 13, 2023

Diabetic Peripheral Neuropathy Trial in United States (VX-548, Pregabalin, Placebo (matched to VX-548))

Recruiting
  • Diabetic Peripheral Neuropathy
  • Banning, California
  • +10 more
Jan 30, 2023

Solid Tumor Trial in Chuo Ku (TRK-950)

Recruiting
  • Solid Tumor
  • TRK-950
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Jul 6, 2022

Acute Pain Trial (VX-548, HB/APAP, Placebo (matched to VX-548))

Recruiting
  • Acute Pain
  • Sheffield, Alabama
  • +16 more
Jan 4, 2023

Acute Pain Trial in United States (VX-548, HB/APAP, Placebo (matched to VX-548))

Recruiting
  • Acute Pain
  • Sheffield, Alabama
  • +10 more
Jan 4, 2023

Cystic Fibrosis Trial in United States (VX-121/TEZ/D-IVA)

Recruiting
  • Cystic Fibrosis
  • Aurora, Colorado
  • +6 more
Jul 26, 2022

Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

Completed
  • Cystic Fibrosis
  • Birmingham, Alabama
  • +96 more
Jan 12, 2023

Time To Complications Occurs in Diabetes

Terminated
  • Retinopathy
  • +4 more
    • Stockholm, Sweden
      Department of Molecular Medicine and Surgery, Rolf Luft Research
    Aug 17, 2022

    Pain Trial in Manchester (VX-993, Placebo)

    Recruiting
    • Pain
    • Manchester, United Kingdom
      MAC Clinical Research
    Jan 6, 2023